1-4 of 4
Kirsteen H. MacLean
Close
Sort by
Journal Articles

Mitochondrial dysfunction in ataxia-telangiectasia

Yasmine A. Valentin-Vega, Kirsteen H. MacLean, Jacqueline Tait-Mulder, Sandra Milasta, Meredith Steeves, Frank C. Dorsey, John L. Cleveland, Douglas R. Green, Michael B. Kastan
Journal: Blood
Blood (2012) 119 (6): 1490–1500.
https://doi.org/10.1182/blood-2011-08-373639
Published: 2012
Includes: Supplemental data
Journal Articles

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine

Andreas Höglund, Lisa M. Nilsson, Linus Plym Forshell, Kirsteen H. Maclean, Jonas A. Nilsson
Journal: Blood
Blood (2009) 113 (18): 4281–4288.
https://doi.org/10.1182/blood-2008-10-183475
Published: 2009
Includes: Supplemental data
Journal Articles

Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA

Steffan T. Nawrocki, Jennifer S. Carew, Kirsteen H. Maclean, James F. Courage, Peng Huang, Janet A. Houghton, John L. Cleveland, Francis J. Giles, David J. McConkey
Journal: Blood
Blood (2008) 112 (7): 2917–2926.
https://doi.org/10.1182/blood-2007-12-130823
Published: 2008
Includes: Supplemental data
Journal Articles

Cellular zinc content is a major determinant of iron chelator–induced apoptosis of thymocytes

Kirsteen H. Maclean, John L. Cleveland, John B. Porter
Journal: Blood
Blood (2001) 98 (13): 3831–3839.
https://doi.org/10.1182/blood.V98.13.3831
Published: 2001